Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology with its Omnipod® products, has announced preliminary revenue results for Q2 2024, ending June 30. Full financial results will be reported on August 8, 2024, followed by a conference…
Schrödinger, Inc. (Nasdaq: SDGR), renowned for its physics-based computational platform, is launching a new initiative to enhance early-stage drug discovery by predicting toxicology risks. This project aims to improve drug development candidates by minimizing the risk of adverse effects from…
The Althaia Foundation is launching an innovative project to prevent falls in frail hospitalized patients using artificial intelligence. In collaboration with Robbie AI, this initiative aims to help healthcare professionals anticipate fall risks and take preventive actions. The pilot study…
Amprion, a leader in advancing the diagnosis of neurodegenerative disorders through seed amplification testing, is unveiling its new line of cerebrospinal fluid (CSF) biomarker panels under the SAAmplify brand. These panels provide physicians and patients with the most comprehensive biomarkers…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of KEYTRUDA, Merck’s anti-PD-1 therapy, in…
The Glycocalyx Research Institute is excited to announce groundbreaking results from a recent study exploring the impact of microvascular health—comprising the vast network of tiny capillaries in the body—on acute side effects from radiation therapy in breast, prostate, and head…
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, has announced that Eisai Inc. (the U.S. subsidiary of Tokyo-based Eisai Co., Ltd.) is among the first to adopt its new AI-driven Medidata Clinical Data Studio. Eisai will…
Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, has announced the successful closing of its public offering. The offering comprised 6,665,000 shares of common stock and Class A warrants to purchase up to 13,330,000 additional…
Maverick Medical AI has announced a significant expansion of its presence in the United States through a new partnership with a leading national medical provider specializing in the outpatient radiology sector. Within just three months, Maverick successfully transitioned the provider…
Flosonics Medical, a leader in wearable medical ultrasound, today announced that Sutter Health, an integrated not-for-profit system based in Northern California, will implement FloPatch, the world’s first wireless, wearable Doppler ultrasound. The FDA-cleared device gives ICU clinicians a fast, hands-free…
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing cancer treatments, has announced the pricing of its underwritten public offering. The offering consists of 13,333,334 shares of common stock along with warrants to purchase up to 13,333,334 shares, priced…
AtriCure, Inc. (Nasdaq: ATRC), a leader in innovative surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain, has announced regulatory approval from China’s National Medical Products Administration (NMPA) to market and sell its AtriClip® Left…